Why are kids with lupus at an increased risk of cardiovascular disease? - Wikidata - awgldk - TriplyDB

Why are kids with lupus at an increased risk of cardiovascular disease?

Why are kids with lupus at an increased risk of cardiovascular disease?

http://www.wikidata.org/entity/Q38591752

about

Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.Differential gene expression profiles in peripheral blood in Northeast Chinese Han people with acute myocardial infarction.

P2860

Q38638596-1B0FDD9A-A597-41BD-A79D-53822545E5A1 Q54943278-5B5F951E-79A0-4946-9BDA-E66B7B0FA933

P2860

Why are kids with lupus at an increased risk of cardiovascular disease?

http://www.wikidata.org/entity/Q38591752

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Why are kids with lupus at an increased risk of cardiovascular disease?

@en

type

label

Why are kids with lupus at an increased risk of cardiovascular disease?

@en

prefLabel

Why are kids with lupus at an increased risk of cardiovascular disease?

@en

P1433

Q38591752-593D77DD-2F5F-45E9-BBDA-E0477CF47A44

P1476

Q38591752-23E014FD-2672-4AB6-A8B7-E59E3B577023

P2093

Q38591752-011C9941-D77F-4648-98A7-BE580C48BFDA

Q38591752-A34FF60F-C89C-4016-8B40-4040E3D55D24

P2860

Q38591752-021324B5-8DDD-4543-80DD-9314BD58670D

Q38591752-03183740-5D98-4108-8EC9-4F0E5EF83B58

Q38591752-034BCF09-2308-4721-B6AF-A39F7B0BBD2B

Q38591752-04896268-075E-4FA8-A60D-004D026E17EF

Q38591752-05152E21-BEBD-4312-8A87-774A6403A5CD

Q38591752-0634D9D9-A265-4CFF-B980-5C87AB65AEE5

Q38591752-06A56EA1-DB56-4DA4-B165-326463B21E5E

Q38591752-084951D6-CB96-45B5-B593-FBFC8C35581E

Q38591752-0D3544A2-8CA1-41C8-BD8F-59B18B2CA383

Q38591752-0E3F9524-13E4-4E43-A420-32AF34DC7123

P2888

Q38591752-CE43BD99-9A73-4B99-AD5E-673D3577BBE7

P304

Q38591752-58F064D9-B82C-49A7-987B-93952891B51F

P31

Q38591752-590E3E56-433C-47F3-BE62-25A5E4A35216

P356

Q38591752-BED3C0B9-D1DE-4B6A-8F20-9F6A8D922733

P433

Q38591752-C8AEABC9-C55E-412A-84BB-1BEA83953B05

P478

Q38591752-3AB032A5-1F85-4083-9054-A66DD33A2513

P50

Q38591752-6E67FD17-EBBE-416A-8DC0-FADE8198B213

P577

Q38591752-EBB9740F-7D03-461D-A558-DD76C1F3F7D1

P5875

Q38591752-F74F7C8C-8584-49F9-901E-0C1318E5F430

P6179

Q38591752-4BEB1F9A-087F-4852-9F0F-5A3E17A01441

P698

Q38591752-1EC5EF37-E11D-49BC-B7D4-A22FD1300E72

P356

S00467-015-3202-7

P1433

Pediatric Nephrology

P1476

Why are kids with lupus at an increased risk of cardiovascular disease?

@en

P2093

Kjell Tullus

http://www.w3.org/2001/XMLSchema#string

Stephen D Marks

http://www.w3.org/2001/XMLSchema#string

P2860

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature

The influence of innate and adaptive immune responses on atherosclerosis

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Preven

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease

Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus

The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus

International physical activity questionnaire: 12-country reliability and validity

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

P2888

s00467-015-3202-7

P304

861-883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-015-3202-7

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Quinlan

P577

2015-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282152824

http://www.w3.org/2001/XMLSchema#string

P6179

1035630128

http://www.w3.org/2001/XMLSchema#string

P698

26399239

http://www.w3.org/2001/XMLSchema#string